Amerisourcebergen Stock Fundamentals
| ABG Stock | EUR 234.90 4.35 1.89% |
AmerisourceBergen fundamentals help investors to digest information that contributes to AmerisourceBergen's financial success or failures. It also enables traders to predict the movement of AmerisourceBergen Stock. The fundamental analysis module provides a way to measure AmerisourceBergen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AmerisourceBergen stock.
AmerisourceBergen |
AmerisourceBergen Company Current Valuation Analysis
AmerisourceBergen's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current AmerisourceBergen Current Valuation | 33.88 B |
Most of AmerisourceBergen's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AmerisourceBergen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, AmerisourceBergen has a Current Valuation of 33.88 B. This is 135.9% higher than that of the Healthcare sector and 155.74% higher than that of the Medical Distribution industry. The current valuation for all Germany stocks is 103.81% lower than that of the firm.
AmerisourceBergen Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AmerisourceBergen's current stock value. Our valuation model uses many indicators to compare AmerisourceBergen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AmerisourceBergen competition to find correlations between indicators driving AmerisourceBergen's intrinsic value. More Info.AmerisourceBergen is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.06 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for AmerisourceBergen is roughly 17.07 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AmerisourceBergen's earnings, one of the primary drivers of an investment's value.AmerisourceBergen Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AmerisourceBergen's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AmerisourceBergen could also be used in its relative valuation, which is a method of valuing AmerisourceBergen by comparing valuation metrics of similar companies.AmerisourceBergen is currently under evaluation in current valuation category among its peers.
AmerisourceBergen Fundamentals
| Return On Equity | 0.5 | |||
| Return On Asset | 0.0294 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 33.88 B | |||
| Shares Outstanding | 202.26 M | |||
| Shares Owned By Insiders | 16.95 % | |||
| Shares Owned By Institutions | 77.85 % | |||
| Price To Earning | 17.93 X | |||
| Price To Book | 5.05 X | |||
| Price To Sales | 0.13 X | |||
| Revenue | 238.59 B | |||
| Gross Profit | 8.33 B | |||
| EBITDA | 3.09 B | |||
| Net Income | 1.7 B | |||
| Cash And Equivalents | 2.88 B | |||
| Cash Per Share | 13.68 X | |||
| Total Debt | 4.63 B | |||
| Debt To Equity | 152.80 % | |||
| Current Ratio | 0.95 X | |||
| Book Value Per Share | (0.88) X | |||
| Cash Flow From Operations | 2.7 B | |||
| Earnings Per Share | 7.77 X | |||
| Price To Earnings To Growth | 1.55 X | |||
| Target Price | 140.85 | |||
| Number Of Employees | 39 K | |||
| Beta | 0.53 | |||
| Market Capitalization | 29.69 B | |||
| Total Asset | 56.56 B | |||
| Z Score | 7.6 | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 1.43 % | |||
| Net Asset | 56.56 B | |||
| Last Dividend Paid | 1.87 |
About AmerisourceBergen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AmerisourceBergen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AmerisourceBergen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AmerisourceBergen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania. AMERISOURCEBERGEN operates under Medical Distribution classification in Germany and is traded on Frankfurt Stock Exchange. It employs 21000 people.
Currently Active Assets on Macroaxis
Other Information on Investing in AmerisourceBergen Stock
AmerisourceBergen financial ratios help investors to determine whether AmerisourceBergen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AmerisourceBergen with respect to the benefits of owning AmerisourceBergen security.